Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.49 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 6/20 | 0.43 |
| ▸ | DGKA | P23743 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19359757 | 1.00 | NAAA (0.52) | NAAACYP4F2CYP4A11EPHX1TSHR | |
| SCHEMBL20834121 | 1.00 | NAAA (0.52) | NAAACYP4F2CYP4A11EPHX1TSHR | |
| SCHEMBL22440467 | 0.98 | NAAA (0.48) | NAAACYP4F2CYP4A11EPHX1TSHR | |
| Hydrochloric Acid SCHEMBL9119589 | 0.96 | NAAA (0.48) | NAAACYP4F2CYP4A11EPHX1TSHR | |
| SCHEMBL23581670 | 0.92 | CYP4F2 (0.58) | NAAACYP4F2CYP4A11EPHX1TSHR | |
| SCHEMBL4809511 | 0.92 | CYP4F2 (0.58) | NAAACYP4F2CYP4A11EPHX1TSHR | |
| SCHEMBL6686460 | 0.92 | CYP4F2 (0.58) | NAAACYP4F2CYP4A11EPHX1TSHR | |
| SCHEMBL1490324 | 0.92 | CYP4F2 (0.58) | NAAACYP4F2CYP4A11EPHX1TSHR | |
| SCHEMBL4809521 | 0.92 | CYP4F2 (0.58) | NAAACYP4F2CYP4A11EPHX1TSHR | |
| SCHEMBL29146085 | 0.92 | CYP4F2 (0.58) | NAAACYP4F2CYP4A11EPHX1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210032222-A1 | FIVE-MEMBERED RING-SUBSTITUTED PYRIDAZINOL COMPOUNDS AND DERIVATIVES, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND APPLICATIONS THEREOF | QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) | 2021-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210032222-A1 | FIVE-MEMBERED RING-SUBSTITUTED PYRIDAZINOL COMPOUNDS AND DERIVATIVES, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND APPLICATIONS THEREOF | CBR3, CBR1, CYP8B1 | NAAA 1797/4885CYP4F2 74/4885CYP4A11 123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.